Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
19.67
+0.12 (0.61%)
At close: Mar 24, 2026, 4:00 PM EDT
19.70
+0.03 (0.15%)
After-hours: Mar 24, 2026, 4:00 PM EDT
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $458.45 million as of March 24, 2026. Its market cap has increased by 111.14% in one year.
Market Cap
458.45M
Enterprise Value
260.71M
1-Year Change
111.14%
Ranking
Category
Stock Price
$19.67
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $458.45M, a decrease of -88.89%. That is a compound annual growth rate of -36.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 455.65M | -30.32% |
| Dec 31, 2025 | 653.89M | 249.70% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 455.87M |
| Assembly Biosciences | 451.45M |
| Atea Pharmaceuticals | 450.94M |
| Fulcrum Therapeutics | 450.88M |
| Rocket Pharmaceuticals | 449.48M |
| Shattuck Labs | 445.13M |
| Absci | 445.10M |
| Aclaris Therapeutics | 445.00M |